Cite

HARVARD Citation

    Jairath, V. et al. (n.d.). P038 Comparing the Efficacy and Safety of Subcutaneous Vedolizumab Versus Adalimumab for the Treatment of Ulcerative Colitis. American journal of gastroenterology. p. . [Online]. 
  
Back to record